The prognostic value of early CA125 serum assay in epithelial ovarian carcinoma
- 1 July 1993
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 68 (1) , 140-145
- https://doi.org/10.1038/bjc.1993.302
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Implications of an overview of chemotherapy in advanced ovarian carcinomaBritish Journal of Cancer, 1992
- The CA 125 tumour-associated antigen: a review of the literatureHuman Reproduction, 1989
- Ovarian cancer: The prognostic value of the serum half-life of CA125 during induction chemotherapyGynecologic Oncology, 1988
- Evaluation of serum CA 125 levels in the monitoring of ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1987
- CA 125 FOR THE MONITORING OF OVARIAN-CARCINOMA DURING PRIMARY THERAPY1987
- Prognosis of surgically determined complete responders in advanced ovarian cancerCancer, 1985
- OVARIAN-CARCINOMA - A MULTIVARIATE-ANALYSIS OF PROGNOSTIC FACTORS1985
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Choice of postoperative therapy based on prognostic factorsInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma.1975